Bendazac - Bio-X ™

CAS: 20187-55-7

Ref. 3D-BB166154

Produktinformation

• Name: Bendazac - Bio-X ™
• Synonyme: 1-(Phenylmethyl)-1H-indazol-3-yloxyacetic acid1-Benzylindazole-3-oxyacetic acid(1-Benzyl-1H-indazol-3-yl)oxyacetic acid, (1-Benzyl-1H-indazol-3-yloxy)-acetic acid, (1-Benzyl-3-indazolyl)oxyacetic acid, 1-Benzylindazole-3-oxyacetic acid, 2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid, 2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid, 2-(1-Benzylindazol-3-yl)oxyacetic acid, 2-[[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic acid, 20187-55-7, Acetic acid, [(1-benzyl-1H-indazol-3-yl)oxy]-, Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, Af 983, Bendazolic Acid, Bindazac, Dogalina, Zildasac, Zildazac, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid, [[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic Acid, acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
• CAS: 20187-55-7

Beschreibung

Bendazac is a non-steroidal anti-inflammatory drug that is used for the treatment of cataracts and other inflammatory conditions such as hives and skin ulcers. Bendazac has an anti-cataract mechanism of action by inhibiting the denaturation of ocular lens proteins. Additionally, it has anti-necrotic and anti-lipidemic properties.

Bendazac is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 282.29 g/mol
• Formel: C₁₆H₁₄N₂O₃
• Reinheit: Min. 95%
• Farbe/Form: Powder
• InChl: InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• InChI Key: InChIKey=BYFMCKSPFYVMOU-UHFFFAOYSA-N
• SMILES: O=C(O)COc1nn(Cc2ccccc2)c2ccccc12